If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> TREATMENT STRATEGIES<br /> ONCOLOGY<br /> Volume 2 Issue 2<br /> <br /> <br /> • Biomarkers<br /> • Breast Cancer<br /> • Gastrointestinal Tumours<br /> • Geriatric Oncology<br /> • Haematological Malignancies<br /> • Lung Cancer<br /> • Lymphoma<br /> • Neuroendocrine Tumours<br /> • Palliative Care<br /> <br /> Articles include:<br /> Angiogenesis: A Target for the Treatment of Ovarian Cancer<br /> <br /> Current Standards and New Trends in the Primary Treatment of<br /> Colon Cancer<br /> <br /> Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Is<br /> it a Standard of Care?<br /> <br /> Minimally Invasive Surgery of Liver Neoplasms<br /> <br /> Treatment Strategies in Neuroendocrine Tumours<br /> <br /> <br /> &l
TREATMENT STRATEGIESONCOLOGYVolume 2 Issue 2
TREATMENT STRATEGIESONCOLOGYVolume 2 Issue 2
TREATMENT STRATEGIESONCOLOGYTreatment Strate
TREATMENT STRATEGIESONCOLOGYTreatment Strate
SARCOMA: THE ONLY THING PROGRESSING IS THE DISEAS
SARCOMA: THE ONLY THING PROGRESSING IS THE DISEAS
CONTENTS...030809113337
CONTENTS...030809113337
Investigating dacomitinib, an irreversiblepan-HE
Investigating dacomitinib, an irreversiblepan-HE
7279838792971011031
7279838792971011031
EDITORIAL ADVISORYPANELTreatment Strategies -
EDITORIAL ADVISORYPANELTreatment Strategies -
Treatment Strategies - ForewordForeword
Treatment Strategies - ForewordForeword
2011European ReviewMultidisciplinary Ca
2011European ReviewMultidisciplinary Ca
Treatment Strategies - Congress Reviewcontinued
Treatment Strategies - Congress Reviewcontinued
22nd Meeting of theEUROPEAN ASSOCIATIONFOR CANC
22nd Meeting of theEUROPEAN ASSOCIATIONFOR CANC
22-25FEBRUARY 2012 ISTANBUL, TURKEY▶ g
22-25FEBRUARY 2012 ISTANBUL, TURKEY▶ g
Interim Data Announced for BIBF 1120 as
Interim Data Announced for BIBF 1120 as
Treatment Strategies - Congress Review2011AWAR
Treatment Strategies - Congress Review2011AWAR
Treatment Strategies - Congress Reviewoncolog
Treatment Strategies - Congress Reviewoncolog
C CAMBRIDGE RESEARCH CENTR
C CAMBRIDGE RESEARCH CENTR
Treatment Strategies - Congress Review MEDIAN
Treatment Strategies - Congress Review MEDIAN
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review
Treatment Strategies - Congress ReviewGE Heal
Treatment Strategies - Congress ReviewGE Heal
Treatment Strategies - Congress Review Del
Treatment Strategies - Congress Review Del
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review
Treatment Strategies - Congress ReviewHigh Bl
Treatment Strategies - Congress ReviewHigh Bl
Treatment Strategies - Congress ReviewAlphara
Treatment Strategies - Congress ReviewAlphara
Treatment Strategies - Congress ReviewMolMed
Treatment Strategies - Congress ReviewMolMed
ROCHE ANNOUNCEENCOURAGING DATA RESULTS ATMULTID
ROCHE ANNOUNCEENCOURAGING DATA RESULTS ATMULTID
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review
Treatment Strategies - Congress ReviewGENETHATI
Treatment Strategies - Congress ReviewGENETHATI
Treatment Strategies - Congress ReviewTHE USE
Treatment Strategies - Congress ReviewTHE USE
Treatment Strategies - Congress ReviewSummary
Treatment Strategies - Congress ReviewSummary
Treatment Strategies - Congress ReviewNew
Treatment Strategies - Congress ReviewNew
Treatment Strategies - Congress Reviewpatient
Treatment Strategies - Congress Reviewpatient
Prognosis of Patients With NETPreviously, tumour
Prognosis of Patients With NETPreviously, tumour
Manchester, UKOctober 25-27, 20121st Ann
Manchester, UKOctober 25-27, 20121st Ann
IASLC Treatment Strategies - Congress Re
IASLC Treatment Strategies - Congress Re
Treatment Strategies - Congress Reviewcontinued
Treatment Strategies - Congress Reviewcontinued
Treatment Strategies - Congress ReviewIASLC A
Treatment Strategies - Congress ReviewIASLC A
Treatment Strategies - Congress ReviewARIAD Pres
Treatment Strategies - Congress ReviewARIAD Pres
RapidArc® for SBRT. Simply Revolutionary.Ster
RapidArc® for SBRT. Simply Revolutionary.Ster
Treatment Strategies - BiomarkersTherapy P
Treatment Strategies - BiomarkersTherapy P
vs. 4.4 months).12 Fewer brain metastases were fo
vs. 4.4 months).12 Fewer brain metastases were fo
Treatment Strategies - Biomarkerserlotinib.19
Treatment Strategies - Biomarkerserlotinib.19
Treatment Strategies - BiomarkersAcknowledgeme
Treatment Strategies - BiomarkersAcknowledgeme
Treatment Strategies - BiomarkersCancer St
Treatment Strategies - BiomarkersCancer St
enchancer was used to express either the c-myc or
enchancer was used to express either the c-myc or
Treatment Strategies - BiomarkersTreatment of
Treatment Strategies - BiomarkersTreatment of
Treatment Strategies - Breast CancerTreatm
Treatment Strategies - Breast CancerTreatm
Treatment Strategies - Breast Cancerwith non-
Treatment Strategies - Breast Cancerwith non-
TNBC, respectively.13,14 In the second trial, exp
TNBC, respectively.13,14 In the second trial, exp
Treatment Strategies - Breast Cancerthe multi
Treatment Strategies - Breast Cancerthe multi
Treatment Strategies - Breast Cancerproteins
Treatment Strategies - Breast Cancerproteins
Treatment Strategies - Breast Cancer(AZD2281)
Treatment Strategies - Breast Cancer(AZD2281)
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Gastrointestinal Tumours
peritoneal disease. The most active induction che
peritoneal disease. The most active induction che
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Gastrointestinal Tumours
Treatment Strategies - Geriatric OncologyW
Treatment Strategies - Geriatric OncologyW
Treatment Strategies - Geriatric Oncology
Treatment Strategies - Geriatric Oncology
Treatment Strategies - Geriatric OncologyDiscu
Treatment Strategies - Geriatric OncologyDiscu
Treatment Strategies - Geriatric OncologyThis
Treatment Strategies - Geriatric OncologyThis
Treatment Strategies - Geriatric Oncologysurg
Treatment Strategies - Geriatric Oncologysurg
Treatment Strategies - Geriatric OncologyC
Treatment Strategies - Geriatric OncologyC
Treatment Strategies - Geriatric Oncologyway
Treatment Strategies - Geriatric Oncologyway
annual meeting. The rst one was a model presente
annual meeting. The rst one was a model presente
Treatment Strategies - Geriatric OncologyRefer
Treatment Strategies - Geriatric OncologyRefer
CAMBRIDGERESEARCHCENTRE HEALTHC
CAMBRIDGERESEARCHCENTRE HEALTHC
Treatment Strategies - Gynaecological Cancer
Treatment Strategies - Gynaecological Cancer
Treatment Strategies - Gynaecological Cancerr
Treatment Strategies - Gynaecological Cancerr
Treatment Strategies - Gynaecological Cancerr
Treatment Strategies - Gynaecological Cancerr
acceptable toxicity pro le when used in combinati
acceptable toxicity pro le when used in combinati
Treatment Strategies - Gynaecological Cancere
Treatment Strategies - Gynaecological Cancere
Treatment Strategies - Gynaecological CancerAn
Treatment Strategies - Gynaecological CancerAn
Treatment Strategies - Gynaecological CancerO
Treatment Strategies - Gynaecological CancerO
Treatment Strategies - Haematological Malignancie
Treatment Strategies - Haematological Malignancie
Treatment Strategies - Haematological Malignancie
Treatment Strategies - Haematological Malignancie
Despite more sophisticated techniques such as `In
Despite more sophisticated techniques such as `In
Treatment Strategies - Haematological Malignancie
Treatment Strategies - Haematological Malignancie
Treatment Strategies - Interventional Oncology
Treatment Strategies - Interventional Oncology
Treatment Strategies - Interventional Oncology
Treatment Strategies - Interventional Oncology
embolised. Integrated Registration on AW VolumeSh
embolised. Integrated Registration on AW VolumeSh
Treatment Strategies - Interventional Oncology
Treatment Strategies - Interventional Oncology
Treatment Strategies - Kidney CancerKidney
Treatment Strategies - Kidney CancerKidney
Treatment Strategies - Kidney Cancerprospecti
Treatment Strategies - Kidney Cancerprospecti
a histology of a non-clear cell type appeared to
a histology of a non-clear cell type appeared to
Treatment Strategies - Kidney Cancerpatient w
Treatment Strategies - Kidney Cancerpatient w
22nd Meeting of theEUROPEAN ASSOCIATIONFOR CANC
22nd Meeting of theEUROPEAN ASSOCIATIONFOR CANC
Treatment Strategies - Liver CancerMinimal
Treatment Strategies - Liver CancerMinimal
application of appropriate adjustment of surgical
application of appropriate adjustment of surgical
Treatment Strategies - Liver Cancerwhich prom
Treatment Strategies - Liver Cancerwhich prom
Treatment Strategies - Liver CancerFirst Autho
Treatment Strategies - Liver CancerFirst Autho
Treatment Strategies - Liver Cancer21. Gagner
Treatment Strategies - Liver Cancer21. Gagner
Treatment Strategies - Lung CancerEarly De
Treatment Strategies - Lung CancerEarly De
Treatment Strategies - Lung Cancerstudies fou
Treatment Strategies - Lung Cancerstudies fou
It is important to put the NLST ndings into pers
It is important to put the NLST ndings into pers
Treatment Strategies - Lung CancerReferences1
Treatment Strategies - Lung CancerReferences1
Treatment Strategies - Lung CancerMulti-disci
Treatment Strategies - Lung CancerMulti-disci
Treatment Strategies - Lung Cancer59 patients
Treatment Strategies - Lung Cancer59 patients
Treatment Strategies - Lung CancerMaintenance
Treatment Strategies - Lung CancerMaintenance
Treatment Strategies - Lung Cancerdemonstrate
Treatment Strategies - Lung Cancerdemonstrate
Treatment Strategies - Lung Cancerbased doubl
Treatment Strategies - Lung Cancerbased doubl
Treatment Strategies - Lung CancerNutritional
Treatment Strategies - Lung CancerNutritional
Treatment Strategies - Lung Cancernutritional
Treatment Strategies - Lung Cancernutritional
22-25FEBRUARY 2012 ISTANBUL, TURKEY▶
22-25FEBRUARY 2012 ISTANBUL, TURKEY▶
Treatment Strategies - LymphomaBendamustine i
Treatment Strategies - LymphomaBendamustine i
Treatment Strategies - Lymphomasix. After 18
Treatment Strategies - Lymphomasix. After 18
option with acceptable toxicity in relapsed/refra
option with acceptable toxicity in relapsed/refra
Treatment Strategies - Lymphomain patients wi
Treatment Strategies - Lymphomain patients wi
Treatment Strategies - LymhpomaThe Basis of
Treatment Strategies - LymhpomaThe Basis of
Treatment Strategies - LymphomaThe p53 Pathway
Treatment Strategies - LymphomaThe p53 Pathway
Therapeutic Options for Refractory CLLTargeting
Therapeutic Options for Refractory CLLTargeting
Treatment Strategies - LymphomaReferences1. G
Treatment Strategies - LymphomaReferences1. G
Treatment Strategies - Neuroendocrine Tumours and
Treatment Strategies - Neuroendocrine Tumours and
Treatment Strategies - Neuroendocrine Tumours and
Treatment Strategies - Neuroendocrine Tumours and
Treatment Strategies - Neuroendocrine Tumours and
Treatment Strategies - Neuroendocrine Tumours and
Treatment Strategies - Palliative CarePati
Treatment Strategies - Palliative CarePati
dose oral lorazepam (1mg) may act synergistically
dose oral lorazepam (1mg) may act synergistically
Treatment Strategies - Palliative CareDuring
Treatment Strategies - Palliative CareDuring
Treatment Strategies - Palliative CareAcknowle
Treatment Strategies - Palliative CareAcknowle
Treatment Strategies - Supportive CareClas
Treatment Strategies - Supportive CareClas
the most well-known. The main idea of bootstrap i
the most well-known. The main idea of bootstrap i
Treatment Strategies - Supportive Carechemoth
Treatment Strategies - Supportive Carechemoth
Treatment Strategies - Supportive Careuntil h
Treatment Strategies - Supportive Careuntil h
Treatment Strategies - Events ListingUpcomin
Treatment Strategies - Events ListingUpcomin
Treatment Strategies - Congress Review8th Eur
Treatment Strategies - Congress Review8th Eur
The Cambridge Research CentreCoppergate House16
The Cambridge Research CentreCoppergate House16